REFERENCES
1. Antibiotic resistance threats in the United States, 2019. Available online: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/2019-ar-threats-report-508.pdf.
2. Chen IR, Lin SN, Wu XN, Chou SH, Wang FD, Lin YT. Clinical and microbiological characteristics of bacteremic pneumonia caused by Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022;12:903682.
3. Guo M, Gao B, Su J, et al. Phenotypic and genetic characterization of hypervirulent Klebsiella pneumoniae in patients with liver abscess and ventilator-associated pneumonia. BMC Microbiol. 2023;23:338.
4. Govindan Nadar R, Chackaravarthy G, Ramachandran G, et al. Isolation and molecular identification of biofilm producing P. aeruginosa and K. pneumoniae from urinary tract infections patient urine sample. J Infect Public Health. 2021;14:1875-80.
5. Roach DJ, Sridhar S, Oliver E, et al. Clinical and genomic characterization of a cohort of patients with Klebsiella pneumoniae bloodstream infection. Clin Infect Dis. 2024;78:31-9.
6. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122:866-73.
7. Hu Y, Yang Y, Feng Y, et al. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: a systematic review of 128 articles across 30 countries. PLoS Med. 2023;20:e1004233.
8. Çölkesen F, Tarakçı A, Eroğlu E, et al. Carbapenem-resistant Klebsiella pneumoniae infection and its risk factors in older adult patients. Clin Interv Aging. 2023;18:1037-45.
9. Lepuschitz S, Hauser K, Schriebl A, et al. Fecal Klebsiella pneumoniae carriage is intermittent and of high clonal diversity. Front Microbiol. 2020;11:581081.
10. Lu B, Zhou H, Zhang X, Qu M, Huang Y, Wang Q. Molecular characterization of Klebsiella pneumoniae isolates from stool specimens of outpatients in sentinel hospitals Beijing, China, 2010-2015. Gut Pathog. 2017;9:39.
11. Raffelsberger N, Hetland MAK, Svendsen K, et al. Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: a cross-sectional study of risk factors and bacterial genomic diversity. Gut Microbes. 2021;13:1939599.
12. Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14.
13. Seki D, Mayer M, Hausmann B, et al. Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage. Cell Host Microbe. 2021;29:1558-1572.e6.
14. Yang J, Li Y, Tang N, et al. The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae. Gut Microbes. 2022;14:2114739.
15. Bray AS, Zafar MA. Deciphering the gastrointestinal carriage of Klebsiella pneumoniae. Infect Immun. 2024;92:e0048223.
16. Hecht AL, Harling LC, Friedman ES, et al. Dietary carbohydrates regulate intestinal colonization and dissemination of Klebsiella pneumoniae. J Clin Invest. 2024;134:e174726.
17. Hyeon JY, Choi YJ, Jung MJ, Lee DH, Song CS, Kim JH. Multidrug-resistant CTX-M-15-positive Klebsiella pneumoniae ST 307 causing bacteremia via gut translocation in a dog. Front Vet Sci. 2023;10:1275822.
18. Hsu CR, Pan YJ, Liu JY, Chen CT, Lin TL, Wang JT. Klebsiella pneumoniae translocates across the intestinal epithelium via Rho GTPase- and phosphatidylinositol 3-kinase/Akt-dependent cell invasion. Infect Immun. 2015;83:769-79.
19. Fung CP, Lin YT, Lin JC, et al. Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess. Emerg Infect Dis. 2012;18:1322-5.
20. Glover JS, Ticer TD, Engevik MA. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci Rep. 2022;12:8456.
21. Bergstrom K, Shan X, Casero D, et al. Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota. Science. 2020;370:467-72.
22. Shuoker B, Pichler MJ, Jin C, et al. Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria. Nat Commun. 2023;14:1833.
23. Elzinga J, Narimatsu Y, de Haan N, Clausen H, de Vos WM, Tytgat HLP. Binding of Akkermansia muciniphila to mucin is O-glycan specific. Nat Commun. 2024;15:4582.
25. Favre-Bonté S, Licht TR, Forestier C, Krogfelt KA. Klebsiella pneumoniae capsule expression is necessary for colonization of large intestines of streptomycin-treated mice. Infect Immun. 1999;67:6152-6.
26. Caballero S, Carter R, Ke X, et al. Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella pneumoniae. PLoS Pathog. 2015;11:e1005132.
27. Hudson AW, Barnes AJ, Bray AS, Ornelles DA, Zafar MA. Klebsiella pneumoniae l-fucose metabolism promotes gastrointestinal colonization and modulates its virulence determinants. Infect Immun. 2022;90:e0020622.
28. Engevik MA, Danhof HA, Auchtung J, et al. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus. Gastroenterology. 2021;160:1301-1314.e8.
29. Landry RM, An D, Hupp JT, Singh PK, Parsek MR. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol. 2006;59:142-51.
30. Søgaard M, Hansen DS, Fiandaca MJ, Stender H, Schønheyder HC. Peptide nucleic acid fluorescence in situ hybridization for rapid detection of Klebsiella pneumoniae from positive blood cultures. J Med Microbiol. 2007;56:914-7.
31. Chen IA, Chu K, Palaniappan K, et al. The IMG/M data management and analysis system v.6.0: new tools and advanced capabilities. Nucleic Acids Res. 2021;49:D751-63.
32. Engevik KA, Hazzard A, Puckett B, et al. Phylogenetically diverse bacterial species produce histamine. Syst Appl Microbiol. 2024;47:126539.
33. Muscariello L, De Siena B, Marasco R. Lactobacillus cell surface proteins involved in interaction with mucus and extracellular matrix components. Curr Microbiol. 2020;77:3831-41.
34. Engevik MA, Ruan W, Esparza M, et al. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites. Physiol Rep. 2021;9:e14719.
35. Jensen H, Roos S, Jonsson H, et al. Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology (Reading). 2014;160:671-81.
36. Ernst CM, Braxton JR, Rodriguez-Osorio CA, et al. Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae. Nat Med. 2020;26:705-11.
37. Taitt CR, Leski TA, Erwin DP, et al. Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in Kenya. PLoS ONE. 2017;12:e0178880.
38. Zheng Y, Ding Y, Xu M, et al. Gut microbiota contributes to host defense against Klebsiella pneumoniae-induced liver abscess. J Inflamm Res. 2021;14:5215-25.
39. Bray AS, Broberg CA, Hudson AW, et al. Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance. Nat Commun. 2025;16:940.
40. Yang Y, van Schaik W, McNally A, Zong Z. Microbiome-mediated colonization resistance to and countermeasures of Klebsiella pneumoniae. Nat Commun. 2026;17:1761.
41. Mccartney AL, Hoyles L. Host interactions of bioactive molecules produced by Klebsiella spp. Microbiota and Host. 2025;3:e240011.
42. Vornhagen J, Rao K, Bachman MA. Gut community structure as a risk factor for infection in Klebsiella pneumoniae-colonized patients. mSystems. 2024;9:e0078624.
43. Liao CH, Kao KL, Wu SI, Yang CJ. Stool microbiota analysis for abundance of genus Klebsiella among adults and children in endemic area for community Klebsiella pneumoniae infection. J Microbiol Immunol Infect. 2024;57:470-9.
44. Wu T, Xu F, Su C, et al. Alterations in the gut microbiome and cecal metabolome during Klebsiella pneumoniae-induced pneumosepsis. Front Immunol. 2020;11:1331.
45. Calderon-Gonzalez R, Lee A, Lopez-Campos G, et al. Modelling the gastrointestinal carriage of Klebsiella pneumoniae infections. mBio. 2023;14:e0312122.
46. Vornhagen J, Rao K, Bachman MA. Gut community structure as a risk factor for infection in Klebsiell-colonized patients. medRxiv 2023. Available online: https://doi.org/10.1101/2023.04.18.23288742. [accessed 17 April 2026].
47. Moreira de Gouveia MI, Bernalier-Donadille A, Jubelin G. Enterobacteriaceae in the human gut: dynamics and ecological roles in health and disease. Biology (Basel). 2024;13:142.
48. Vega L, Birchenall-Jiménez CI, Aponte A, et al. Contrasting the gut microbiome in Colombian patients with diarrhea: a comparative metagenomic study in hospitalization and emergency room services. Gut Pathog. 2026;18:20.
49. Federici S, Kredo-Russo S, Valdés-Mas R, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell. 2022;185:2879-2898.e24.
50. Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017;358:359-65.
51. Kharaghani AA, Harzandi N, Khorsand B, Rajabnia M, Kharaghani AA, Houri H. High prevalence of mucosa-associated extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae among iranain patients with inflammatory bowel disease (IBD). Ann Clin Microbiol Antimicrob. 2023;22:86.
52. Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:733992.
53. Olamafar E, Yadegar A, Shahrokh S, Ebrahimi MT, Houri H. Pathogenic potential of invasive mucosa-associated Klebsiella pneumoniae isolates in ulcerative colitis: characterization of virulence factors and inflammatory response. Immun Inflamm Dis. 2025;13:e70285.
54. Hong W, Yang J, Cheng Y, et al. Bacteria co-colonizing with Clostridioides difficile in two asymptomatic patients. Open Life Sci. 2019;14:628-37.
55. Wang L, Chen X, Pollock NR, et al. Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI diarrhea. Gut Microbes. 2025;17:2505269.
56. Jiang Q, Xu Q, Kenéz Á, Chen S, Yang G. Klebsiella pneumoniae infection is associated with alterations in the gut microbiome and lung metabolome. Microbiol Res. 2022;263:127139.
57. Engevik MA, Engevik AC, Engevik KA, et al. Mucin-degrading microbes release monosaccharides that chemoattract Clostridioides difficile and facilitate colonization of the human intestinal mucus layer. ACS Infect Dis. 2021;7:1126-42.
58. Ng KM, Ferreyra JA, Higginbottom SK, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502:96-9.
59. Chang DE, Smalley DJ, Tucker DL, et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A. 2004;101:7427-32.
60. Jeong HG, Oh MH, Kim BS, Lee MY, Han HJ, Choi SH. The capability of catabolic utilization of N-acetylneuraminic acid, a sialic acid, is essential for Vibrio vulnificus pathogenesis. Infect Immun. 2009;77:3209-17.
61. Pezzicoli A, Ruggiero P, Amerighi F, Telford JL, Soriani M. Exogenous sialic acid transport contributes to group B streptococcus infection of mucosal surfaces. J Infect Dis. 2012;206:924-31.
62. North RA, Horne CR, Davies JS, et al. “Just a spoonful of sugar...”: import of sialic acid across bacterial cell membranes. Biophys Rev. 2018;10:219-27.
63. Vimr ER, Troy FA. Identification of an inducible catabolic system for sialic acids (nan) in Escherichia coli. J Bacteriol. 1985;164:845-53.
64. Severi E, Hosie AH, Hawkhead JA, Thomas GH. Characterization of a novel sialic acid transporter of the sodium solute symporter (SSS) family and in vivo comparison with known bacterial sialic acid transporters. FEMS Microbiol Lett. 2010;304:47-54.
65. Huang YL, Chassard C, Hausmann M, von Itzstein M, Hennet T. Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat Commun. 2015;6:8141.
66. Almagro-Moreno S, Boyd EF. Insights into the evolution of sialic acid catabolism among bacteria. BMC Evol Biol. 2009;9:118.
67. Horne CR, Venugopal H, Panjikar S, et al. Mechanism of NanR gene repression and allosteric induction of bacterial sialic acid metabolism. Nat Commun. 2021;12:1988.
68. Afzal M, Shafeeq S, Ahmed H, Kuipers OP. Sialic acid-mediated gene expression in Streptococcus pneumoniae and role of NanR as a transcriptional activator of the nan gene cluster. Appl Environ Microbiol. 2015;81:3121-31.
69. Ramakrishnan R, Nair AV, Parmar K, Rajmani RS, Chakravortty D, Das D. Combating biofilm-associated Klebsiella pneumoniae infections using a bovine microbial enzyme. NPJ Biofilms Microbiomes. 2024;10:119.
70. Guerra MES, Destro G, Vieira B, et al. Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front Cell Infect Microbiol. 2022;12:877995.
71. Li Y, Ni M. Regulation of biofilm formation in Klebsiella pneumoniae. Front Microbiol. 2023;14:1238482.
72. Centeleghe I, Norville P, Hughes L, Maillard JY. Klebsiella pneumoniae survives on surfaces as a dry biofilm. Am J Infect Control. 2023;51:1157-62.
73. Piperaki ET, Syrogiannopoulos GA, Tzouvelekis LS, Daikos GL. Klebsiella pneumoniae: virulence, biofilm and antimicrobial resistance. Pediatr Infect Dis J. 2017;36:1002-5.
74. Zaborskytė G, Coelho P, Wrande M, Sandegren L. Rapid evolution of Klebsiella pneumoniae biofilms in vitro delineates adaptive changes selected during infection. bioRxiv 2024. Available online: https://www.biorxiv.org/content/10.1101/2024.03.16.585345v1.full.pdf.
75. Gomes AÉI, Pacheco T, Dos Santos CDS, et al. Functional insights from KpfR, a new transcriptional regulator of fimbrial expression that is crucial for Klebsiella pneumoniae pathogenicity. Front Microbiol. 2020;11:601921.
76. Beckman RL 4th, Cella E, Azarian T, Rendueles O, Fleeman RM. Diverse polysaccharide production and biofilm formation abilities of clinical Klebsiella pneumoniae. NPJ Biofilms Microbiomes. 2024;10:151.
77. Guilhen C, Charbonnel N, Parisot N, et al. Transcriptional profiling of Klebsiella pneumoniae defines signatures for planktonic, sessile and biofilm-dispersed cells. BMC Genomics. 2016;17:237.
78. Liu K, Tan S, Ye W, Hou L, Fang B. Low-concentration iron promotes Klebsiella pneumoniae biofilm formation by suppressing succinic acid. BMC Microbiol. 2022;22:95.
79. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2003;47:1251-6.
80. Pacheco T, Gomes AÉI, Siqueira NMG, et al. SdiA, a quorum-sensing regulator, suppresses fimbriae expression, biofilm formation, and quorum-sensing signaling molecules production in Klebsiella pneumoniae. Front Microbiol. 2021;12:597735.
81. Furtado KL, Plott L, Markovetz M, et al. Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation. mSphere. 2024;9:e0008124.
82. Co JY, Cárcamo-Oyarce G, Billings N, et al. Mucins trigger dispersal of Pseudomonas aeruginosa biofilms. NPJ Biofilms Microbiomes. 2018;4:23.
83. Yang S, Boboltz A, Stern A, Rathi V, Duncan G. Synthetic mucus biomaterials synergize with antibiofilm agents to combat Pseudomonas aeruginosa biofilms. Adv Ther. 2025;8:2400359.
84. Zhang X, Li Q, Lin H, et al. High-Level Aminoglycoside resistance in human clinical Klebsiella pneumoniae complex isolates and characteristics of armA-carrying IncHI5 plasmids. Front Microbiol. 2021;12:636396.
85. Ahmed OB, Asghar AH, Bamaga M, Bahwerth FS, Ibrahim ME. Characterization of aminoglycoside resistance genes in multidrug-resistant Klebsiella pneumoniae collected from tertiary hospitals during the COVID-19 pandemic. PLoS ONE. 2023;18:e0289359.
86. Foudraine DE, Strepis N, Stingl C, et al. Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics. Sci Rep. 2021;11:12472.
87. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol. 2011;9:356-68.
88. Tonetti FR, Eguileor A, Llorente C. Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases. eGastroenterology. 2024;2:e100098.
89. Chatupheeraphat C, Peamchai J, Luk-In S, Eiamphungporn W. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol. 2023;13:1153868.
90. Kadry AA, El-Antrawy MA, El-Ganiny AM. Impact of short chain fatty acids (SCFAs) on antimicrobial activity of new β-lactam/β-lactamase inhibitor combinations and on virulence of Escherichia coli isolates. J Antibiot (Tokyo). 2023;76:225-35.
91. Lang M, Carvalho A, Baharoglu Z, Mazel D. Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules. Microbiol Mol Biol Rev. 2023;87:e0003622.
92. Farha MA, Verschoor CP, Bowdish D, Brown ED. Collapsing the proton motive force to identify synergistic combinations against staphylococcus aureus. Chem Biol. 2013;20:1168-78.
93. Webster CM, Shepherd M. A mini-review: environmental and metabolic factors affecting aminoglycoside efficacy. World J Microbiol Biotechnol. 2022;39:7.
94. Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987;51:439-57.
95. Zdarska V, Arcari G, Kolar M, Mlynarcik P. Antibiotic resistance in Klebsiella pneumoniae and related enterobacterales: molecular mechanisms, mobile elements, and therapeutic challenges. Antibiotics (Basel). 2026;15:37.
96. Li Y, Kumar S, Zhang L. Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist. 2024;17:1107-19.
97. Sharma R, Yeshwante S, Bui NM, et al. A novel role for colistin as an efflux pump inhibitor in multidrug-resistant Klebsiella pneumoniae. Sci Rep. 2025;15:34612.
98. Devi BT, Aditya V, Kini S, Kumar BK, Deekshit VK. Synergistic effects of antibiotics and efflux pump inhibitors on multidrug-resistant Escherichia coli and Klebsiella pneumoniae. J Appl Microbiol. 2025;136:lxaf169.
99. Huy TXN. Overcoming Klebsiella pneumoniae antibiotic resistance: new insights into mechanisms and drug discovery. Beni-Suef Univ J Basic Appl Sci. 2024;13:13.
100. Filgona J, Banerjee T, Anupurba S. Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India. J Infect Dev Ctries. 2015;9:815-20.
